 David Irwin
Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 16 | 2026 | 312 | 6.470 |
Why?
| | Hemoglobins | 11 | 2026 | 381 | 3.230 |
Why?
| | Hemopexin | 5 | 2025 | 38 | 2.570 |
Why?
| | Hypertension, Pulmonary | 12 | 2026 | 1946 | 2.380 |
Why?
| | beta-Thalassemia | 2 | 2025 | 40 | 1.630 |
Why?
| | Hemolysis | 8 | 2026 | 242 | 1.620 |
Why?
| | Haptoglobins | 5 | 2026 | 66 | 1.620 |
Why?
| | Hypoxia | 11 | 2026 | 1193 | 1.170 |
Why?
| | Altitude Sickness | 4 | 2016 | 141 | 1.140 |
Why?
| | Exercise Tolerance | 4 | 2025 | 282 | 1.090 |
Why?
| | Altitude | 4 | 2022 | 473 | 1.070 |
Why?
| | Iron | 4 | 2025 | 356 | 1.050 |
Why?
| | Lung | 7 | 2025 | 4084 | 1.040 |
Why?
| | Heme | 3 | 2025 | 89 | 1.030 |
Why?
| | Pulmonary Edema | 3 | 2019 | 105 | 1.030 |
Why?
| | Muscle, Skeletal | 4 | 2025 | 1784 | 0.800 |
Why?
| | Animals | 40 | 2026 | 37800 | 0.760 |
Why?
| | Spleen | 1 | 2025 | 507 | 0.750 |
Why?
| | Oxygen | 5 | 2024 | 978 | 0.720 |
Why?
| | Pulmonary Ventilation | 1 | 2022 | 82 | 0.720 |
Why?
| | Rats | 17 | 2024 | 5553 | 0.690 |
Why?
| | Capillary Permeability | 4 | 2016 | 132 | 0.650 |
Why?
| | Vascular Remodeling | 3 | 2022 | 203 | 0.650 |
Why?
| | Disease Models, Animal | 14 | 2026 | 4525 | 0.640 |
Why?
| | Beta vulgaris | 1 | 2020 | 14 | 0.640 |
Why?
| | Pulmonary Artery | 6 | 2022 | 1124 | 0.630 |
Why?
| | Proteome | 1 | 2025 | 512 | 0.620 |
Why?
| | Rats, Sprague-Dawley | 12 | 2024 | 2512 | 0.620 |
Why?
| | Emulsions | 1 | 2019 | 57 | 0.610 |
Why?
| | Atrial Natriuretic Factor | 3 | 2005 | 55 | 0.600 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 948 | 0.600 |
Why?
| | Vasodilator Agents | 2 | 2013 | 329 | 0.590 |
Why?
| | Blood Substitutes | 2 | 2009 | 27 | 0.570 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 601 | 0.550 |
Why?
| | Fluorocarbons | 1 | 2019 | 119 | 0.550 |
Why?
| | Mice | 19 | 2026 | 18218 | 0.540 |
Why?
| | Oxygen Consumption | 3 | 2024 | 715 | 0.520 |
Why?
| | Physical Exertion | 1 | 2018 | 205 | 0.520 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2016 | 14 | 0.500 |
Why?
| | Cerebral Veins | 1 | 2016 | 16 | 0.500 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 37 | 0.500 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2016 | 25 | 0.490 |
Why?
| | Microvessels | 1 | 2018 | 98 | 0.490 |
Why?
| | Brain Edema | 1 | 2016 | 62 | 0.490 |
Why?
| | Water | 1 | 2019 | 465 | 0.480 |
Why?
| | Cerebral Arteries | 1 | 2016 | 59 | 0.480 |
Why?
| | Liver | 1 | 2025 | 1884 | 0.470 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 379 | 0.470 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2013 | 95 | 0.460 |
Why?
| | Macrophages | 2 | 2023 | 1496 | 0.460 |
Why?
| | Muscle Contraction | 1 | 2018 | 429 | 0.440 |
Why?
| | Angiogenesis Inhibitors | 1 | 2016 | 236 | 0.440 |
Why?
| | Exercise | 2 | 2024 | 2183 | 0.420 |
Why?
| | Transcriptional Activation | 2 | 2013 | 372 | 0.400 |
Why?
| | Endothelial Cells | 2 | 2013 | 862 | 0.400 |
Why?
| | Vascular Diseases | 2 | 2015 | 251 | 0.390 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 117 | 0.370 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5954 | 0.370 |
Why?
| | Inflammation | 4 | 2026 | 2862 | 0.360 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2014 | 294 | 0.360 |
Why?
| | Glutaral | 1 | 2009 | 13 | 0.300 |
Why?
| | Male | 21 | 2026 | 72263 | 0.290 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2009 | 35 | 0.290 |
Why?
| | Lung Diseases | 2 | 2015 | 780 | 0.290 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2009 | 72 | 0.290 |
Why?
| | Proteomics | 3 | 2025 | 1182 | 0.290 |
Why?
| | Phenylpropionates | 2 | 2019 | 27 | 0.280 |
Why?
| | Oxidative Stress | 4 | 2025 | 1331 | 0.280 |
Why?
| | Sulfones | 1 | 2009 | 126 | 0.280 |
Why?
| | Pyridazines | 2 | 2019 | 57 | 0.280 |
Why?
| | Vascular Resistance | 3 | 2016 | 367 | 0.270 |
Why?
| | Endothelins | 2 | 2018 | 61 | 0.270 |
Why?
| | Disease Progression | 3 | 2023 | 2844 | 0.260 |
Why?
| | Polymers | 2 | 2009 | 484 | 0.260 |
Why?
| | Nitric Oxide | 3 | 2018 | 894 | 0.250 |
Why?
| | Humans | 26 | 2026 | 144298 | 0.240 |
Why?
| | Lipid Peroxidation | 3 | 2018 | 160 | 0.240 |
Why?
| | Piperazines | 1 | 2009 | 378 | 0.240 |
Why?
| | Respiration | 2 | 2022 | 204 | 0.240 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 549 | 0.240 |
Why?
| | Extracorporeal Circulation | 1 | 2026 | 14 | 0.240 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 241 | 0.230 |
Why?
| | Cell Nucleus | 1 | 2009 | 591 | 0.230 |
Why?
| | Transferrin | 1 | 2025 | 50 | 0.230 |
Why?
| | Blood Pressure | 5 | 2018 | 1763 | 0.220 |
Why?
| | Muscle, Smooth, Vascular | 4 | 2017 | 440 | 0.220 |
Why?
| | Capillary Leak Syndrome | 1 | 2005 | 12 | 0.220 |
Why?
| | Cardiac Output | 3 | 2012 | 178 | 0.220 |
Why?
| | Cation Transport Proteins | 1 | 2026 | 118 | 0.220 |
Why?
| | Lignans | 1 | 2024 | 12 | 0.220 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2025 | 34 | 0.210 |
Why?
| | Neprilysin | 1 | 2005 | 47 | 0.210 |
Why?
| | Heme Oxygenase-1 | 1 | 2025 | 74 | 0.210 |
Why?
| | Biphenyl Compounds | 1 | 2024 | 66 | 0.210 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 70 | 0.210 |
Why?
| | NAD | 1 | 2024 | 82 | 0.210 |
Why?
| | Sirtuin 3 | 1 | 2024 | 58 | 0.200 |
Why?
| | Aerosols | 1 | 2025 | 187 | 0.200 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 129 | 0.200 |
Why?
| | Endothelin-1 | 1 | 2005 | 181 | 0.190 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 296 | 0.190 |
Why?
| | Pulmonary Circulation | 2 | 2019 | 429 | 0.190 |
Why?
| | Glycolysis | 1 | 2025 | 340 | 0.190 |
Why?
| | Oxidation-Reduction | 3 | 2018 | 1073 | 0.190 |
Why?
| | Antibodies | 2 | 2021 | 396 | 0.180 |
Why?
| | Oxyhemoglobins | 1 | 2021 | 28 | 0.170 |
Why?
| | Magnetics | 1 | 2021 | 47 | 0.170 |
Why?
| | Scleroderma, Systemic | 1 | 2022 | 123 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 572 | 0.160 |
Why?
| | Muscle Proteins | 1 | 2022 | 240 | 0.160 |
Why?
| | Monocytes | 1 | 2023 | 534 | 0.160 |
Why?
| | Metabolic Diseases | 1 | 2021 | 114 | 0.160 |
Why?
| | CD40 Antigens | 1 | 2021 | 89 | 0.160 |
Why?
| | Extracellular Vesicles | 1 | 2023 | 170 | 0.160 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 172 | 0.160 |
Why?
| | Up-Regulation | 2 | 2013 | 847 | 0.160 |
Why?
| | Alternative Splicing | 1 | 2022 | 245 | 0.160 |
Why?
| | Endotoxins | 1 | 2001 | 217 | 0.150 |
Why?
| | Histone Deacetylases | 2 | 2012 | 207 | 0.150 |
Why?
| | Nitrates | 1 | 2020 | 100 | 0.150 |
Why?
| | Phenotype | 2 | 2026 | 3139 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 231 | 0.150 |
Why?
| | Gadolinium | 1 | 2019 | 84 | 0.150 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 193 | 0.140 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2018 | 12 | 0.140 |
Why?
| | Cell Line | 2 | 2015 | 2821 | 0.140 |
Why?
| | Blood Gas Analysis | 2 | 2008 | 81 | 0.140 |
Why?
| | Carrier Proteins | 1 | 2022 | 733 | 0.140 |
Why?
| | Metabolome | 1 | 2021 | 383 | 0.140 |
Why?
| | Double-Blind Method | 2 | 2020 | 2032 | 0.140 |
Why?
| | Aminophylline | 1 | 2017 | 12 | 0.130 |
Why?
| | Liver Diseases | 1 | 2021 | 304 | 0.130 |
Why?
| | Antioxidants | 2 | 2013 | 542 | 0.130 |
Why?
| | Lipids | 2 | 2023 | 702 | 0.130 |
Why?
| | Cells, Cultured | 6 | 2014 | 4102 | 0.130 |
Why?
| | Lipoproteins | 1 | 2018 | 164 | 0.130 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 16 | 0.130 |
Why?
| | Deferoxamine | 1 | 2016 | 27 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2017 | 2485 | 0.130 |
Why?
| | Acetazolamide | 1 | 2016 | 26 | 0.130 |
Why?
| | Acclimatization | 1 | 2018 | 172 | 0.120 |
Why?
| | Niacinamide | 1 | 2016 | 86 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2022 | 3106 | 0.120 |
Why?
| | NF-kappa B | 2 | 2013 | 656 | 0.120 |
Why?
| | Dietary Supplements | 1 | 2020 | 575 | 0.120 |
Why?
| | Myocytes, Cardiac | 3 | 2022 | 538 | 0.120 |
Why?
| | Oligonucleotides | 1 | 2016 | 151 | 0.120 |
Why?
| | Methemoglobin | 2 | 2021 | 24 | 0.110 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2018 | 355 | 0.110 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 512 | 0.110 |
Why?
| | Signal Transduction | 5 | 2017 | 5182 | 0.110 |
Why?
| | Vasoconstriction | 1 | 2016 | 216 | 0.110 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 149 | 0.100 |
Why?
| | Cattle | 2 | 2008 | 971 | 0.100 |
Why?
| | Chloride Channels | 1 | 2014 | 33 | 0.100 |
Why?
| | RNA, Small Interfering | 3 | 2012 | 629 | 0.100 |
Why?
| | Catalase | 1 | 2013 | 130 | 0.100 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 85 | 0.100 |
Why?
| | Genomics | 1 | 2018 | 828 | 0.100 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2012 | 218 | 0.100 |
Why?
| | Permeability | 1 | 2013 | 168 | 0.100 |
Why?
| | Indoles | 1 | 2016 | 500 | 0.090 |
Why?
| | Interleukin-6 | 1 | 2017 | 770 | 0.090 |
Why?
| | Ventricular Remodeling | 2 | 2012 | 275 | 0.090 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 32 | 0.090 |
Why?
| | Infusion Pumps | 1 | 2012 | 33 | 0.090 |
Why?
| | Spin Labels | 1 | 2012 | 59 | 0.090 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 368 | 0.090 |
Why?
| | Heart Failure | 2 | 2022 | 2323 | 0.090 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 262 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 268 | 0.090 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 300 | 0.090 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 276 | 0.090 |
Why?
| | Cerebellum | 1 | 2013 | 222 | 0.080 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 2170 | 0.080 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 332 | 0.080 |
Why?
| | Microcirculation | 2 | 2014 | 141 | 0.080 |
Why?
| | Blotting, Western | 1 | 2012 | 1160 | 0.080 |
Why?
| | Sildenafil Citrate | 1 | 2009 | 60 | 0.070 |
Why?
| | Pneumonia | 1 | 2015 | 627 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 120 | 0.070 |
Why?
| | Hypoxia, Brain | 1 | 2008 | 9 | 0.070 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2008 | 48 | 0.070 |
Why?
| | Purines | 1 | 2009 | 187 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2177 | 0.070 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 234 | 0.070 |
Why?
| | Epinephrine | 1 | 2008 | 154 | 0.060 |
Why?
| | Norepinephrine | 1 | 2008 | 195 | 0.060 |
Why?
| | Hemodynamics | 1 | 2012 | 1113 | 0.060 |
Why?
| | Female | 7 | 2022 | 78137 | 0.060 |
Why?
| | Dogs | 1 | 2008 | 435 | 0.060 |
Why?
| | Mesocricetus | 1 | 2026 | 46 | 0.060 |
Why?
| | Protein Isoforms | 2 | 2022 | 393 | 0.060 |
Why?
| | Myocardium | 1 | 2011 | 927 | 0.060 |
Why?
| | Cricetinae | 1 | 2026 | 296 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2013 | 2808 | 0.060 |
Why?
| | Stress Fibers | 1 | 2004 | 18 | 0.060 |
Why?
| | Stroke Volume | 1 | 2008 | 650 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 819 | 0.050 |
Why?
| | Allyl Compounds | 1 | 2024 | 26 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2025 | 333 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2019 | 11713 | 0.050 |
Why?
| | Sirtuins | 1 | 2024 | 48 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1493 | 0.050 |
Why?
| | Heart Rate | 1 | 2008 | 849 | 0.050 |
Why?
| | Phenols | 1 | 2024 | 107 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 264 | 0.050 |
Why?
| | Actins | 1 | 2004 | 421 | 0.050 |
Why?
| | Hypertension | 1 | 2011 | 1259 | 0.050 |
Why?
| | Catecholamines | 1 | 2022 | 87 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 66 | 0.040 |
Why?
| | Thrombin | 1 | 2023 | 165 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 322 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2643 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 854 | 0.040 |
Why?
| | Etanercept | 1 | 2021 | 60 | 0.040 |
Why?
| | Salmonella enteritidis | 1 | 2001 | 17 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2018 | 3595 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2004 | 1206 | 0.040 |
Why?
| | Protein Binding | 1 | 2026 | 2241 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 661 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 355 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 454 | 0.040 |
Why?
| | Metabolomics | 1 | 2025 | 722 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 447 | 0.040 |
Why?
| | Erythrocytes | 1 | 2025 | 750 | 0.040 |
Why?
| | Heart | 1 | 2022 | 625 | 0.030 |
Why?
| | Guinea Pigs | 1 | 2018 | 159 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2018 | 249 | 0.030 |
Why?
| | Tissue Donors | 1 | 2021 | 412 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 248 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2021 | 503 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 161 | 0.030 |
Why?
| | Cytoskeleton | 1 | 2018 | 195 | 0.030 |
Why?
| | Genetics, Population | 1 | 2018 | 215 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 1011 | 0.030 |
Why?
| | Heart Ventricles | 2 | 2012 | 750 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 441 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2014 | 396 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 318 | 0.030 |
Why?
| | Adenosine | 1 | 2017 | 255 | 0.030 |
Why?
| | Sarcoma, Experimental | 1 | 2014 | 6 | 0.030 |
Why?
| | Rats, Nude | 1 | 2014 | 25 | 0.030 |
Why?
| | Intravital Microscopy | 1 | 2014 | 24 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 1044 | 0.030 |
Why?
| | Heterografts | 1 | 2014 | 143 | 0.030 |
Why?
| | Coronary Vessels | 1 | 2016 | 246 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1807 | 0.030 |
Why?
| | Genotype | 1 | 2018 | 1843 | 0.020 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 85 | 0.020 |
Why?
| | Swine | 1 | 2016 | 817 | 0.020 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 196 | 0.020 |
Why?
| | Blood Flow Velocity | 1 | 2014 | 419 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2043 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2014 | 283 | 0.020 |
Why?
| | Chemistry, Physical | 1 | 2012 | 39 | 0.020 |
Why?
| | Fructans | 1 | 1992 | 1 | 0.020 |
Why?
| | Genes, Immunoglobulin | 1 | 1992 | 29 | 0.020 |
Why?
| | MicroRNAs | 1 | 2018 | 689 | 0.020 |
Why?
| | Immunoglobulin Variable Region | 1 | 1992 | 80 | 0.020 |
Why?
| | Immunoglobulin Light Chains | 1 | 1992 | 51 | 0.020 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 1992 | 85 | 0.020 |
Why?
| | Adult | 3 | 2023 | 40408 | 0.020 |
Why?
| | Mitochondria | 1 | 2018 | 981 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1762 | 0.020 |
Why?
| | Histone Deacetylase 6 | 1 | 2011 | 17 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 2134 | 0.020 |
Why?
| | Young Adult | 2 | 2018 | 14092 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 224 | 0.020 |
Why?
| | Adenoviridae | 1 | 2011 | 199 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 513 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 472 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 518 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1046 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5948 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 601 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3520 | 0.020 |
Why?
| | Middle Aged | 2 | 2018 | 35892 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1501 | 0.010 |
Why?
| | Child | 1 | 2023 | 22562 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2014 | 2363 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 22370 | 0.010 |
Why?
| | Antibody Diversity | 1 | 1992 | 16 | 0.010 |
Why?
| | Immunoglobulin Isotypes | 1 | 1992 | 35 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1992 | 178 | 0.010 |
Why?
|
|
Irwin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|